These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33433418)

  • 1. Clinical value of the detection of
    Zhu Y; Zhu F; Wang L; Zhai X; Shan X
    Indian J Pathol Microbiol; 2021; 64(1):107-110. PubMed ID: 33433418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell HE staining smears and paired cell paraffin sections in detection of epithelial growth factor receptor gene of pleural fluid specimens.
    Hou F; Qi C; Lu Y; Li F; Hao Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):35-44. PubMed ID: 35545361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Epidermal Growth Factor Receptor Gene Mutations Identified Using Pleural Effusion and Primary Tumor Tissue Samples in Non-Small Cell Lung Cancer.
    Liu N; Sun RZ; Du J; Dong QZ; Fan CF; Li QC; Wang EH; Liu Y
    Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):e44-e51. PubMed ID: 28800007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer.
    Jian G; Songwen Z; Ling Z; Qinfang D; Jie Z; Liang T; Caicun Z
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1341-7. PubMed ID: 20155428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of EGFR Mutations Detected in Pleural Effusion and Its 
Clinical Significance in 132 Patients with Advanced Non-small Cell Lung Cancer: 
A Retrospective Study in A Single Center].
    Lu T; Li Q; Li L; Yang K; Zhou D; Gao J; Chen M; Xu Y; Zhong W; Wang M; Liang Z; Zhao J
    Zhongguo Fei Ai Za Zhi; 2020 Dec; 23(12):1059-1065. PubMed ID: 33357312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting outcomes of EGFR-targeted therapy in non-small cell lung cancer patients using pleural effusions samples and peptide nucleic acid probe assay.
    Wang MC; Wang CL; Chen TL; Chang JW; Lu JJ; Chang PY; Chiou CC
    Clin Chem Lab Med; 2017 Oct; 55(12):1979-1986. PubMed ID: 28787267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens.
    Xu H; Sun W; Zhang G; Cheng Y
    J BUON; 2015; 20(1):142-5. PubMed ID: 25778309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients.
    Kimura H; Fujiwara Y; Sone T; Kunitoh H; Tamura T; Kasahara K; Nishio K
    Cancer Sci; 2006 Jul; 97(7):642-8. PubMed ID: 16827805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing.
    Yeo CD; Kim JW; Kim KH; Ha JH; Rhee CK; Kim SJ; Kim YK; Park CK; Lee SH; Park MS; Yim HW
    Lung Cancer; 2013 Aug; 81(2):207-12. PubMed ID: 23726527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of EGFR mutation in supernatant, cell pellets of pleural effusion and tumor tissues from non-small cell lung cancer patients by high resolution melting analysis and sequencing.
    Lin J; Gu Y; Du R; Deng M; Lu Y; Ding Y
    Int J Clin Exp Pathol; 2014; 7(12):8813-22. PubMed ID: 25674250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.
    Ellison G; Zhu G; Moulis A; Dearden S; Speake G; McCormack R
    J Clin Pathol; 2013 Feb; 66(2):79-89. PubMed ID: 23172555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer.
    Rizzo S; Petrella F; Buscarino V; De Maria F; Raimondi S; Barberis M; Fumagalli C; Spitaleri G; Rampinelli C; De Marinis F; Spaggiari L; Bellomi M
    Eur Radiol; 2016 Jan; 26(1):32-42. PubMed ID: 25956936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
    Chu H; Zhong C; Xue G; Liang X; Wang J; Liu Y; Zhao S; Zhou Q; Bi J
    Oncol Rep; 2013 Nov; 30(5):2311-5. PubMed ID: 24002698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of epidermal growth factor receptor gene mutation in lung adenocarcinoma using biopsied tissue, pleural effusion and blood samples].
    Shi Y; Ma ZP; Cui WL; Pang XL; Zhang W; Ma YQ
    Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):775-779. PubMed ID: 30317733
    [No Abstract]   [Full Text] [Related]  

  • 15. Droplet digital PCR improved the EGFR mutation diagnosis with pleural fluid samples in non-small-cell lung cancer patients.
    Li X; Liu Y; Shi W; Xu H; Hu H; Dong Z; Zhu G; Sun Y; Liu B; Gao H; Tang C; Liu X
    Clin Chim Acta; 2017 Aug; 471():177-184. PubMed ID: 28602964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis.
    Yoshimura A; Yamada T; Tsuji T; Hamashima R; Shiotsu S; Yuba T; Takumi C; Uchino J; Hiraoka N; Takayama K
    Thorac Cancer; 2019 Mar; 10(3):557-563. PubMed ID: 30672656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].
    Sun MH; Yang F; Shen L; Zhang L; Chen Y; Cai X; Zhu XL; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):655-9. PubMed ID: 22321541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.
    Lozano MD; Zulueta JJ; Echeveste JI; Gúrpide A; Seijo LM; Martín-Algarra S; Del Barrio A; Pio R; Idoate MA; Labiano T; Perez-Gracia JL
    Oncologist; 2011; 16(6):877-85. PubMed ID: 21572125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.
    Liu X; Lu Y; Zhu G; Lei Y; Zheng L; Qin H; Tang C; Ellison G; McCormack R; Ji Q
    J Clin Pathol; 2013 Dec; 66(12):1065-9. PubMed ID: 23888061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome comparisons between exons 19 and 21 EGFR mutations for non-small-cell lung cancer patients with malignant pleural effusion after first-line and second-line tyrosine kinase inhibitors.
    Zheng Z; Xie D; Su H; Lin B; Zhao L; Deng X; Chen H; Fei S; Jin X; Xie C
    Tumour Biol; 2017 Jun; 39(6):1010428317706211. PubMed ID: 28618947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.